XSpray Pharma AB
€5
0
+€0.05+1.01% 今天
統計
當日最高
5.17
當日最低
4.95
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
-
市盈率
-
股息收益率
-
股息
-
即將到來
收益
6Nov預期
預期每股收益
-1.43159988755616
實際每股收益
N/A
人們還關注
此列表基於在 Stock Events 上關注 6XP.F 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
關於
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Show more...
首席執行官
Dr. Per Andersson Ph.D.
員工
23
國家
SE
ISIN
SE0009973563
WKN
000A2H48J